Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

Share Price is delayed by 15 minutes
Get Live Data
3,885.00    -45.00 (-1.15%)
Bid:
3,885.00
Ask:
3,900.00
Spread: 15.00 (0.386%)
Market Cap: £1.20b
CGEO Live PriceLast checked at - London Stock Exchange

Intraday Georgia Capital Share Chart

Director/PDMR Shareholding

29 Dec 2022 16:29

RNS Number : 2480L
Georgia Capital PLC
29 December 2022
 

London, 29 December 2022

 

 

 

Georgia Capital announces market purchase of shares for its Executive Equity Compensation Trust

 

Georgia Capital PLC (CGEO or the Group) was notified by Sanne Fiduciary Services Limited (Sanne), acting as trustee of the JSC Georgia Capital Executive Equity Compensation Trust (the Trust), that Sanne, through an independent broker, purchased in the market 65,791 CGEO ordinary shares with a nominal value of £0.01 each (Shares) at a price of £7.34 (rounded to two decimal points) per Share, traded on 29 December 2022 with a settlement date of 03 January 2023.

 

The Trust holds the Shares for the purpose of satisfying awards to be awarded to beneficiaries of the Trust. The executive directors and persons discharging managerial responsibility of the Group are potential beneficiaries under the Trust and are therefore treated as having an interest in such Shares. Upon settlement of the above transaction, the Trust will hold a total of 4,250,021 Shares, representing approximately 9.48% of CGEO's issued ordinary share capital.

 

Of the 4,250,021 Shares held by the Trust, 2,069,737 are allocated to existing awards.

 

 

Name of authorised official of issuer responsible for making notification: Link Company Matters Limited, Company Secretary

 

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a retail (pharmacy) business, (ii) a hospitals business, (iii) an insurance business (P&C and medical insurance); (iv) a clinics and diagnostics business, (v) a renewable energy business (hydro and wind assets) and (vi) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20.0% equity stake in the water utility business and a 20.3% equity stake (at 30-Sep-22) in LSE premium-listed Bank of Georgia Group PLC ("BoG"), a leading universal bank in Georgia.

JSC Georgia Capital has, as of the date hereof, the following credit ratings:

S&P Global

'B+'/FC & 'B+'/LC

Moody's

B1/CFR & B1/PDR

 For further information, please visit www.georgiacapital.ge or contact:

 

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Shalva Bukia

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

+ 995 322 005 045

ir@gcap.ge

ir@gcap.ge

ir@gcap.ge

 


This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKLFLLLLLFBV
Date   Source Headline
4th Mar 20265:16 pmRNSTransaction in Own Shares
4th Mar 20262:03 pmRNSCancellation of Treasury Shares
3rd Mar 20265:06 pmRNSTransaction in Own Shares
2nd Mar 20265:26 pmRNSTransaction in Own Shares
2nd Mar 20261:06 pmRNSTotal Voting Rights
27th Feb 20265:02 pmRNSTransaction in Own Shares
26th Feb 20265:51 pmRNSTransaction in Own Shares
25th Feb 20265:08 pmRNSTransaction in Own Shares
24th Feb 20265:21 pmRNSTransaction in Own Shares
24th Feb 20267:10 amRNSCommencement of US$ 50 million buyback programme
24th Feb 20267:00 amRNSFinal Results
16th Feb 20265:15 pmRNSHolding(s) in Company
9th Feb 202611:55 amRNSNotice of Results
2nd Feb 20269:10 amRNSTotal Voting Rights
28th Jan 20265:09 pmRNSHolding(s) in Company
28th Jan 202611:14 amRNSCancellation of Treasury Shares
22nd Jan 20265:39 pmRNSTransaction in Own Shares
22nd Jan 202610:48 amRNSCancellation of Treasury Shares
21st Jan 20265:16 pmRNSTransaction in Own Shares
21st Jan 20262:28 pmRNSHolding(s) in Company
20th Jan 202610:48 amRNSTransaction in Own Shares
19th Jan 20262:08 pmRNSTransaction in Own Shares
16th Jan 20265:06 pmRNSTransaction in Own Shares
15th Jan 20261:37 pmRNSTransaction in Own Shares
15th Jan 202612:45 pmRNSCancellation of Treasury Shares
14th Jan 20265:24 pmRNSTransaction in Own Shares
13th Jan 20264:11 pmRNSTransaction in Own Shares
12th Jan 20261:27 pmRNSTransaction in Own Shares
9th Jan 20265:30 pmRNSTransaction in Own Shares
8th Jan 20265:12 pmRNSTransaction in Own Shares
7th Jan 20264:50 pmRNSTransaction in Own Shares
7th Jan 20263:45 pmRNSCancellation of Treasury Shares
7th Jan 20263:36 pmRNSDirector/PDMR Shareholding
6th Jan 20263:42 pmRNSTransaction in Own Shares
5th Jan 20263:12 pmRNSTransaction in Own Shares
2nd Jan 20263:15 pmRNSTransaction in Own Shares
2nd Jan 202610:15 amRNSTotal Voting Rights
31st Dec 20251:34 pmRNSCANCELLATION OF TREASURY SHARES
31st Dec 20251:34 pmRNSCANCELLATION OF TREASURY SHARES
31st Dec 20251:34 pmRNSTransaction in Own Shares
31st Dec 20251:34 pmRNSTransaction in Own Shares
30th Dec 20255:05 pmRNSTransaction in Own Shares
30th Dec 20255:05 pmRNSTransaction in Own Shares
29th Dec 20255:03 pmRNSTransaction in Own Shares
29th Dec 20255:03 pmRNSTransaction in Own Shares
24th Dec 20251:14 pmRNSTransaction in Own Shares
24th Dec 20251:14 pmRNSTransaction in Own Shares
24th Dec 202511:08 amRNSCancellation of Treasury Shares
24th Dec 202511:08 amRNSCancellation of Treasury Shares
23rd Dec 20255:16 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.